Stockreport

Turn Therapeutics to Present at Upcoming TD Cowen and Oppenheimer Healthcare Conferences

Turn Therapeutics Inc.  (TTRX) 
PDF LOS ANGELES--(BUSINESS WIRE)--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted inflammatory and immunology therapies [Read more]